Navigation Links
Insulet Appoints Peter J. Devlin as Chief Commercial Officer
Date:8/17/2009

BEDFORD, Mass., Aug. 17 /PRNewswire-FirstCall/ --Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology with its OmniPod(R) Insulin Management System, today announced the appointment of Peter J. Devlin as Chief Commercial Officer. In this newly created role, Mr. Devlin will lead the Company's Sales and Marketing, Business Development, Clinical Research and Customer Care operations.

"Peter brings a distinguished track record in the diabetes and medical device industries and we are extremely pleased to have him join Insulet's management team," said Duane DeSisto, president & chief executive officer of Insulet. "Peter's proven ability to develop and implement successful commercial strategies globally will be invaluable to Insulet as we continue to grow our core insulin pump business and expand into new opportunities for the easy-to-use OmniPod System."

Mr. Devlin spent the last 11 years at Abbott Laboratories, most recently serving as Divisional Vice President of Global Strategic Marketing, Diabetes Care. In this role, he was responsible for the development of commercial strategies, global brand management, market research, area strategic marketing, and business analytics and forecasting. Previously, Mr. Devlin served as Marketing Manager of i-STAT Corporation, a point-of-care blood analysis systems company, which was acquired by Abbott. Prior, Mr. Devlin spent eight years at C.R. Bard Inc., where he held various product management and engineering roles of increasing responsibility. Mr. Devlin holds a Bachelor of Science degree in Mechanical Engineering from the University of Massachusetts.

"I am eager to join Insulet at this exciting time as the OmniPod System transitions from being a new technology to the standard of care in the insulin pump market," said Mr. Devlin. "I am also excited to help Insulet realize the promise of its innovative delivery system in a broad range of therapies."

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Contact:
    Stephanie Marks for Insulet Corporation
    ir@insulet.com
    877-PODD-IR1 (877-763-3471)


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Corporation to Present at Upcoming Investor Conferences
2. Insulet Corporation to Report Second Quarter 2009 Financial Results on Tuesday, August 4, 2009
3. Insulet Establishes Eco-Friendly Disposal Program for the OmniPod(R) Insulin Management System
4. Insulet Applauds Employee for Bronze Medal Performance in World Blind Sailing Championships
5. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
6. Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
7. Insulet Receives $60 Million Funding Commitment
8. Insulet Reports Fourth Quarter and Year End 2008 Results
9. Insulet Corporation to Report Fourth Quarter and Full Year 2008 Financial Results on Thursday, March 5, 2009
10. Insulet Corporation to Present at the J.P. Morgan Healthcare Conference on January 14, 2009
11. Insulet Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... 2016 , ... To succeed under value-based payments, healthcare providers ... how to move forward, given the need to sustain current operations. PYA has ... an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare providers want ...
(Date:6/24/2016)... ... 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona has re-located to ... vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new retreat center ... as well as the Sedona Rouge, both popular accommodations for SpiritQuest clients. The ...
(Date:6/23/2016)... ... June 23, 2016 , ... An article published June 8 ... between head and neck cancer in individuals with unhealthy oral hygiene habits. The article ... on whether they had gum disease, brushed their teeth on a daily basis, wore ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: